Jump to navigation
With yesterday's verdict in New Jersey, Merck has now won more than half of the Vioxx liability lawsuits filed against it. Is the decision to fight individual cases paying off? Helen Palmer reports.
<iframe src="http://www.marketplace.org/node/17940/player/storyplayer" frameborder="0" scrolling="no" width="100%" height="240px"></iframe>